Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Conditions
Interventions
- DRUG: recombinant interleukin-11
- DRUG: recombinant interleukin-11
- DRUG: recombinant interleukin-11
Sponsor
University of Pittsburgh
Collaborators
- [object Object]
- [object Object]